New CytoSure Microarray for Cancer Research
23 Apr 2013In this video Spencer Howell discusses the new CytoSure Cancer +SNP array available from Oxford Gene Technology (OGT) for the superior detection of copy number variation and loss of heterozygosity on a single array. Spencer tells SelectScience more about the CytoSure product range and explains how in addition to offering gene-focused arrays the company also provides custom arrays. Spencer also discusses the company’s software solutions for interpreting microarray and next generation sequencing data. Interview filmed by SelectScience at AACR 2013.
Related Products
Request Quote for All Products
CytoSure™ Cancer +SNP Array
Oxford Gene Technology LtdReliable detection of copy number changes and loss of heterozygosity on a single array for haematological malignancies and solid cancers. The CytoSure Cancer +SNP array delivers: ■ Flexible choice of reference sample ■ Confident detection of CNV and LOH on a single array ■ An optimised design allowing identification of key genomic aberrations ■ Cancer-specific tracks enabling fast and easy data generation and interpretation of cytogenetic results
